MedPath

COPHYLAC EXPECTORANT

COPHYLAC EXPECTORANT

Discontinued
DIN Number

00116351

Drug Class

Human

Market Date

Dec 31, 1958

Company
HC

hoechst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00116351
AIG Number0304365001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05DA20 COMBINATIONS
Product Specifications
Dosage FormDrops
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

EMETINE HYDROCHLORIDEActive
Strength: 1.3 MG / ML
Monograph: EMETINE HYDROCHLORIDE
NORMETHADONE HYDROCHLORIDEActive
Strength: 10 MG / ML
Monograph: NORMETHADONE HYDROCHLORIDE
P-HYDROXYEPHEDRINE HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: P-HYDROXYEPHEDRINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.